Saturday, 19 February 2022

Covaxin to Be Evaluated as Covid-19 Vaccine Candidate in US as USFDA Lifts Clinical Hold

Overall, Covaxin has more than 15 publications elucidating all aspects of the safety, immunogenicity, efficacy and effectiveness, in adults and ch

from Top Business News- News18.com https://ift.tt/4gTjPYZ
Previous Post
Next Post

post written by:

0 comments: